Prevalence of QT prolongation and associated LVEF changes in diabetic patients over a four-year retrospective time period.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28638571)

Published in J Community Hosp Intern Med Perspect on June 06, 2017

Authors

Zhongju Lu1, Lloyd Lense2, Mohit Sharma1, Ankit Shah1, Ying Luu1, Lucien Cardinal1, Joan Faro1, Alan Kaell1

Author Affiliations

1: Department of Internal Medicine, John T. Mather Memorial Hospital, Port Jefferson, NY, USA.
2: Division of Cardiology, Stony Brook University Hospital, Stony Brook, NY, USA.

Articles cited by this

Sudden cardiac death. Circulation (1998) 9.41

Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes (1974) 5.55

QT interval prolongation predicts cardiovascular mortality in an apparently healthy population. Circulation (1991) 4.37

AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part IV: the ST segment, T and U waves, and the QT interval: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology. J Am Coll Cardiol (2009) 2.82

The incidence of congestive heart failure in type 2 diabetes: an update. Diabetes Care (2004) 2.79

Suppression of phosphoinositide 3-kinase signaling and alteration of multiple ion currents in drug-induced long QT syndrome. Sci Transl Med (2012) 1.99

QT interval: how to measure it and what is "normal". J Cardiovasc Electrophysiol (2006) 1.89

Sunitinib malate for the treatment of metastatic renal cell carcinoma and gastrointestinal stromal tumors. Clin Ther (2007) 1.64

Mechanisms of [Ca2+]i transient decrease in cardiomyopathy of db/db type 2 diabetic mice. Diabetes (2006) 1.49

QT and QTc dispersion are accurate predictors of cardiac death in newly diagnosed non-insulin dependent diabetes: cohort study. BMJ (1998) 1.41

Prolonged QTc interval predicts mortality in patients with Type 1 diabetes mellitus. Diabet Med (2001) 1.34

Sudden death prevention in patients with advanced ventricular dysfunction. Circulation (1993) 1.23

Loss of cardiac phosphoinositide 3-kinase p110 alpha results in contractile dysfunction. Circulation (2009) 1.22

Influence of diabetes mellitus on heart failure risk and outcome. Cardiovasc Diabetol (2003) 1.12

Electrocardiographic strain pattern and prediction of cardiovascular morbidity and mortality in hypertensive patients. Hypertension (2004) 1.12

The relation between QTc interval prolongation and diabetic complications. The EURODIAB IDDM Complication Study Group. Diabetologia (1999) 1.11

Tyrosine kinase inhibitors: the first decade. Curr Hematol Malig Rep (2010) 1.11

Predictors of mortality in acute heart failure: interaction between diabetes and impaired left ventricular ejection fraction. Eur J Heart Fail (2014) 1.10

QTc interval and resting heart rate as long-term predictors of mortality in type 1 and type 2 diabetes mellitus: a 23-year follow-up. Diabetologia (2006) 1.09

Decreased L-type Ca2+ current in cardiac myocytes of type 1 diabetic Akita mice due to reduced phosphatidylinositol 3-kinase signaling. Diabetes (2007) 1.05

Length of the QT interval: determinants and prognostic implications in a population-based prospective study of older men. J Electrocardiol (2008) 1.04

Mortality and predictors of mortality in a cohort of Brazilian type 2 diabetic patients. Diabetes Care (2004) 1.03

Sudden cardiac death after myocardial infarction in patients with type 2 diabetes. Heart Rhythm (2010) 1.01

Heart rate-corrected QT interval is an independent predictor of all-cause and cardiovascular mortality in individuals with type 2 diabetes: the Diabetes Heart Study. Diabetes Care (2014) 0.98

Prevalence of Q-T interval dispersion in type 1 diabetes and its relation with cardiac ischemia : the EURODIAB IDDM Complications Study Group. Diabetes Care (2002) 0.95

Clinical features of subclinical left ventricular systolic dysfunction in patients with diabetes mellitus. Cardiovasc Diabetol (2015) 0.94

Incidence and risk factors of prolonged QTc interval in type 1 diabetes: the EURODIAB Prospective Complications Study. Diabetes Care (2007) 0.94

Effects of metoprolol on heart rate variability in survivors of acute myocardial infarction. Am J Cardiol (1993) 0.94

Evaluation of five QT correction formulas using a software-assisted method of continuous QT measurement from 24-hour Holter recordings. Am J Cardiol (1996) 0.93

Relation of systemic blood pressure, left ventricular mass, insulin sensitivity, and coronary artery disease to QT interval duration in nondiabetic and type 2 diabetic subjects. Am J Cardiol (2000) 0.93

Increased persistent sodium current due to decreased PI3K signaling contributes to QT prolongation in the diabetic heart. Diabetes (2013) 0.91

The correlation among QTc interval, hyperglycaemia and the impaired autonomic activity. Auton Neurosci (2009) 0.90

QTc interval prolongation and QTc dispersion in children and adolescents with type 1 diabetes. J Pediatr (2002) 0.88

Prevalence and risk factors of prolonged QTc interval among Chinese patients with type 2 diabetes. Exp Diabetes Res (2012) 0.88

Prevalence and prognosis of left ventricular systolic dysfunction in asymptomatic diabetic patients without known coronary artery disease referred for stress single-photon emission computed tomography and assessment of left ventricular function. Am Heart J (2007) 0.87

Restoration of defective L-type Ca2+ current in cardiac myocytes of type 2 diabetic db/db mice by Akt and PKC-ι. J Cardiovasc Pharmacol (2011) 0.84

Influencing factors of QTc among the clinical characteristics in type 2 diabetes mellitus. Diabetes Res Clin Pract (2010) 0.83

Heart failure due to systolic dysfunction and mortality in diabetes: pooled analysis of 39,505 subjects. J Card Fail (2008) 0.82

Diabetes reduces left ventricular ejection fraction--irrespective of presence and extent of coronary artery disease. Eur J Endocrinol (2011) 0.82

Fasting serum insulin concentrations are associated with QTc duration independent of serum leptin, percent body fat, and BMI. Diabetes Care (1999) 0.82

The impact of metabolic control and QTc prolongation on all-cause mortality in patients with type 2 diabetes and foot ulcers. Diabetologia (2013) 0.81

Articles by these authors

LA inhalers for COPD: perceptions/reality of ABCD GOLD tool use. J Community Hosp Intern Med Perspect (2020) 0.75